Successful Opening of Ductus Arteriosus with Milrinone in a Newborn with Tetralogy of Fallot and Pulmonary Atresia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tetralogy of Fallot (TOF) assumes its’ most severe form when accompanied by pulmonary atresia (PA). Preserving the patent ductus arteriosus to maintain pulmonary blood flow is life-saving for patients with this congenital heart disease. Milrinone, a selective phosphodiesterase III inhibitor, is a potent vasodilator. Here, we report the successful use of milrinone for a newborn infant with TOF and PA for keeping the ductus arteriosus open and thereby maintaining pulmonary circulation. Milrinone is a useful drug because of its inotropic, lusitropic, and pulmonary vasodilating effects, in addition to its ability to keep the ductus arteriosus open and its relatively mild side-effects. Case series and comparative studies will be needed in the future to verify the effectiveness of this drug.
Abstract
Tetralogy of Fallot (TOF) assumes its’ most severe form when accompanied by pulmonary atresia (PA). Preserving the patent ductus arteriosus to maintain pulmonary blood flow is life-saving for patients with this congenital heart disease. Milrinone, a selective phosphodiesterase III inhibitor, is a potent vasodilator. Here, we report the successful use of milrinone for a newborn infant with TOF and PA for keeping the ductus arteriosus open and thereby maintaining pulmonary circulation. Milrinone is a useful drug because of its inotropic, lusitropic, and pulmonary vasodilating effects, in addition to its ability to keep the ductus arteriosus open and its relatively mild side-effects. Case series and comparative studies will be needed in the future to verify the effectiveness of this drug.
참고문헌 (17)
- Hayes JS, "Molecular basis for the cardiovascular activities of amrinone and AR-L57", J Pharmacol Exp Ther, 230, pp.124~132 (1984)
- Chang AC, "Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery", Crit Care Med, 23, pp.1907~1914 (1995)
- In DK, "Experience of milrinone treatment for persistent pulmonary hypertension of the newborn", J Korean Soc Neonatol, 13, pp.201~208 (2006)
- Paradisis M, "Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants", J Pediatr, 154, pp.189~195 (2009)
- Bernstein D, "Tetralogy of Fallot with pulmonary atresia. In Nelson Textbook of Pediatrics. 19th ed", pp.1578~1580 (2011), Philadelphia: Elsevier Saunders
- Schneider DJ, "Patent ductus arteriosus", Circulation, 114, pp.1873~1882 (2006)
- Kaufman MB, "Bone and tissue changes following prostaglandin therapy in neonates", Ann Pharmacother, 30, pp.269~277 (1996)
- Lewis AB, "Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease", Circulation, 64, pp.893~898 (1981)
- Jentzer JH, "Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs", Am J Cardiol, 48, pp.75~83 (1981)
- LeJemtel TH, "Effects of phosphodiesterase inhibition on skeletal muscle vasculature", Am J Cardiol, 63, pp.27A~30A (1989)
- Silver PJ, "Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle", J Cardiovasc Pharmacol, 13, pp.530~540 (1989)
- Wynands JE, "Amrinone: is it the inotrope of choice", J Cardiothorac Anesth, 3(6 Suppl 2), pp.45~57 (1989)
- Ramamoorthy C, "Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery", Anesth Analg, 86, pp.283~289 (1998)
- Hoffman TM, "Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease", Circulation, 107, pp.996~1002 (2003)
- Toyoshima K, "In vivo dilatation of the fetal and postnatal ductus arteriosus by inhibition of phosphodiesterase 3 in rats", Biol Neonate, 89, pp.251~256 (2006)
- Sehgal A, "Use of milrinone in the management of haemodynamic instability following duct ligation", Eur J Pediatr, 170, pp.115~119 (2011)
- Sehgal A, "Haemodynamically unstable preterm infant: an unresolved management conundrum", Eur J Pediatr, 170, pp.1237~1245 (2011)